Both in Pharmaceuticals
Nexentis Technologies vs Valion Bio
Over the past year NXTS returned −63.9% and VBIO returned −75.7%; their daily moves had a correlation of 0.08.
NXTS −63.9% VBIO −75.7%Growth of $1, one year, split-adjusted
| Metric | NXTS | VBIO |
|---|---|---|
| Price | $0.5853 | $0.5500 |
| Market cap | $850.6K | $1.2M |
| Today | −7.24% | −10.83% |
| 1 month | −59.1% | −78.1% |
| 6 months | — | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.5M | -$5.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | — |
| Short % of float | 2.5% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).